Circulation. 2005;112:341-349
Published online before print July 11, 2005,
doi: 10.1161/CIRCULATIONAHA.105.553735
(Circulation. 2005;112:341-349.)
© 2005 American Heart Association, Inc.
Histamine Induces Tissue Factor Expression
Implications for Acute Coronary Syndromes
Jan Steffel, MD;
Alexander Akhmedov, PhD;
Helen Greutert;
Thomas F. Lüscher, MD;
Felix C. Tanner, MD
From Cardiovascular Research, Physiology Institute, University of Zürich (J.S., A.A., H.G., T.F.L., F.C.T.), Center for Integrative Human Physiology, University of Zürich (J.S., A.A., H.G., T.F.L., F.C.T.), and Cardiology, Cardiovascular Center, University Hospital Zürich (J.S., T.F.L., F.C.T.), Zürich, Switzerland.
Correspondence to Felix C. Tanner, MD, Cardiovascular Research, Physiology Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland. E-mail felix.tanner{at}access.unizh.ch
Received August 20, 2004; revision received November 28, 2004; second revision received April 5, 2005; accepted April 11, 2005.
Background— Histamine can induce coronary vasospasm, leading to variant angina and acute myocardial infarction. However, the role of histamine in thrombus formation is ill defined. Hence, this study investigates whether histamine induces tissue factor (TF) expression in vascular cells.
Methods and Results— Histamine (10–8 to 10–5 mol/L) induced TF expression in a concentration-dependent manner in human aortic endothelial and vascular smooth muscle cells, whereas TF pathway inhibitor expression remained unaffected. RT-PCR and Northern blotting revealed that histamine stimulated TF mRNA transcription, peaking at 1 hour. Protein expression increased 18-fold (P<0.02) with a maximum at 5 hours, which was paralleled by a 4-fold augmentation in surface activity (P<0.01). These effects were completely prevented by pretreatment with the H1 receptor antagonists mepyramine (P<0.0001), chlorpheniramine, and diphenhydramine but not the H2 receptor antagonist cimetidine (P=NS). Histamine induced a time-dependent, H1 receptor–mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK). Blocking of p38, ERK, or JNK with SB203580 (P<0.0001), PD98059 (P<0.0001), or SP600125 (P<0.0001), respectively, impaired histamine-induced TF expression in a concentration-dependent manner. In contrast, histamine-stimulated TF expression was increased by phosphatidylinositol 3-kinase inhibition with LY294002 or wortmannin, whereas it was not affected by Rho-kinase inhibition with Y-27632 or hydroxyfasudil.
Conclusions— Histamine induces expression of TF, but not TF pathway inhibitor, in vascular cells via activation of the H1, but not H2, receptor. This effect is mediated by the MAP kinases p38, ERK, and JNK. This observation may open novel perspectives in the treatment of variant angina and acute coronary syndromes.
Key Words: coagulation • coronary disease • endothelium • signal transduction • thrombosis
This article has been cited by other articles:
|
|
|
|
 
G. G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T. F. Luscher, and F. C. Tanner
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
Eur. Heart J.,
June 29, 2009;
(2009)
ehp259v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Luscher, and F.C. Tanner
Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2008;
28(4):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Stahli, A. Breitenstein, A. Akhmedov, G. G. Camici, K. Shojaati, N. Bogdanov, J. Steffel, D. Ringli, T. F. Luscher, and F. C. Tanner
Cardiac Glycosides Regulate Endothelial Tissue Factor Expression in Culture
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2007;
27(12):
2769 - 2776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Hermann and C. M. Matter
Tissue Plasminogen Activator Induced Reperfusion Injury After Stroke Revisited
Circulation,
July 24, 2007;
116(4):
363 - 365.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhao, S. Zhou, and C.-K. Heng
Impact of Serum Amyloid A on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Activity in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1645 - 1650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C. M. Matter, Z. Yang, T. F. Luscher, et al.
Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents
Circulation,
October 3, 2006;
114(14):
1512 - 1521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Stahli, G. G. Camici, J. Steffel, A. Akhmedov, K. Shojaati, M. Graber, T. F. Luscher, and F. C. Tanner
Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH2 Kinase Activation
Circ. Res.,
July 21, 2006;
99(2):
149 - 155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Steffel, T. F. Luscher, and F. C. Tanner
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Circulation,
February 7, 2006;
113(5):
722 - 731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Steffel, R. A. Latini, A. Akhmedov, D. Zimmermann, P. Zimmerling, T. F. Luscher, and F. C. Tanner
Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design
Circulation,
September 27, 2005;
112(13):
2002 - 2011.
[Abstract]
[Full Text]
[PDF]
|
|
|
